| OA17.02 | A synergistic model of engagement: the ECHO Global Community Advisory Group and HC-HIV Advocacy Working Group | Oral Abstract Session | Community engagement in prevention research |
| OA12.04LB | A VSV-based HIV-1 vaccine provides protection in macaques against low dose cross-clade SHIVenv_SF162_P3 challenge | Oral Abstract Session | Novel vaccine and other prevention approaches |
| OA13.03 | Acceptability of telemedicine and HIV self-test among PrEP users during the COVID-19 pandemic in Brazil | Oral Abstract Session | Implementation science, including structural interventions, PrEP & VMMC |
| OA08.04 | Active tuberculosis co-infection enhances HIV-1 specific humoral immunity | Oral Abstract Session | Humoral immunity |
| PE20.06 | Acute sexual violence exposure dysregulates HIV associated cervical immune biomarkers in women | E-poster | Mucosal immunity |
| OA05.02 | Acute SIV Induces BHLH gene variants prior to adaptive natural killer cell formation | Oral Abstract Session | Innate and trained immunity |
| PE16.10 | Adherence to the event-driven PrEP regimen within the Amsterdam PrEP demonstration project: analysis based on online diary data | E-poster | Humoral immunity |
| PE01.31 | Adolescent girls and young women's (AGYW) PrEP-user journey during an implementation science study in South Africa and Kenya | E-poster | Behavioural and social science research |
| PE23.02 | Adoption of WHO's HIV retesting policy for HIV-negative women during the breastfeeding period in 10 high HIV-burden African countries | E-poster | Policy and advocacy |
| PE21.04LB | Advances in the use of a bacterially derived glycoside for inducing oligomannose-targeted neutralizing antibodies to HIV-1 | E-poster | Novel vaccine and other prevention approaches |